Imre Sandor B.
- Country
- Romania
- Department
- Cardiology
Research Overview
- J3L-MC-EZEB: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3819469 in Adults with Elevated Lipoprotein(a)
- Evaluation of Inclisiran's Efficacy in Reducing Major Adverse Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Efficacy, Safety, and Tolerability of JTT-861 in Heart Failure with Reduced Ejection Fraction: A Phase 2a Randomized, Double-blind, Placebo-controlled Study
Data & Insights
Has run more than one trial at 64 of 408 partner sites.
Specializations
Cardiovascular Prevention
The investigator specializes in primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD), with particular focus on innovative therapeutic approaches for reducing cardiovascular events.
- Primary prevention strategies in high-risk patients
- Management of established ASCVD
- Cardiovascular risk reduction interventions
Research interests include novel lipid-modifying therapies and their impact on cardiovascular outcomes.
Cardiac Conditions
The investigator focuses on treating complex cardiac conditions, particularly heart failure with reduced ejection fraction (HFrEF) and hypertrophic cardiomyopathy.
- Heart failure management
- Obstructive and non-obstructive cardiomyopathy
- Cardiac function improvement strategies
Areas of interest include symptom management and functional improvement in cardiac patients.
Specialized Therapeutic Areas
The investigator's expertise extends to lipoprotein disorders and atrial fibrillation, with emphasis on developing therapeutic solutions for patients with limited treatment options.
- Lipoprotein(a) reduction therapies
- Atrial fibrillation management
- Alternative anticoagulation approaches
Research focus includes novel therapeutic agents for complex cardiovascular disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.